Is MBRX or MDCX more undervalued in 2026?

CirclFi compares Moleculin Biotech, Inc. (MBRX) and Medicus Pharma Ltd. (MDCX) using 13 institutional-grade valuation models. MBRX has a Quality of Company score of 4.3/10 while MDCX scores 3.2/10.

Which is a better buy — MBRX or MDCX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do MBRX and MDCX valuations compare?

MBRX at $2.79 and MDCX at $0.38 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

MBRX vs MDCX Valuation Comparison 2026 — Intrinsic Value Analysis

MBRX

Pharmaceutical Preparations

Moleculin Biotech, Inc.

Quality

4.3

out of 10

Value Trap

SAFE

Price

$2.79

Last close

Models

7/13

Active

MDCX

Pharmaceutical Preparations

Medicus Pharma Ltd.

Quality

3.2

out of 10

Value Trap

SAFE

Price

$0.38

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	MBRX Fair Value	MBRX Upside	MDCX Fair Value	MDCX Upside
Bayesian DCF	Intrinsic	$1.66	-40.5%	$0.11	-69.8%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$7.87	+182.2%	$1.16	+207.1%
Dynamic NAV	Asset-Based	$6.78	+143.1%	$0.21	-43.4%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for MBRX vs MDCX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

MBRX vs MDCX — Which Stock Is More Undervalued?

MBRX scores higher with a 4.3/10 quality rating vs MDCX's 3.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Moleculin Biotech, Inc. (MBRX) and Medicus Pharma Ltd. (MDCX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

MBRX currently trades at $2.79 with a QOC of 4.3/10, while MDCX trades at $0.38 with a QOC of 3.2/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).